These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9607293)

  • 1. [Hepatitis associated with treatment with lovastatin. Presentation of 2 cases].
    Bruguera M; Joya P; Rodés J
    Gastroenterol Hepatol; 1998 Mar; 21(3):127-8. PubMed ID: 9607293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cholestatic hepatitis during simvastatin administration.
    Ballaré M; Campanini M; Catania E; Bordin G; Zaccala G; Monteverde A
    Recenti Prog Med; 1991 Apr; 82(4):233-5. PubMed ID: 1857844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinically manifest liver lesions during use of simvastatin].
    Koornstra JJ; Ottervanger JP; Fehmers MC; Stricker BH
    Ned Tijdschr Geneeskd; 1996 Apr; 140(15):846-8. PubMed ID: 8668280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute cholestatic hepatitis associated with pravastatin.
    Hartleb M; Rymarczyk G; Januszewski K
    Am J Gastroenterol; 1999 May; 94(5):1388-90. PubMed ID: 10235223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HMG-CoA reductase inhibitors and sexual dysfunction].
    Pía Iglesias G; Fernández Fernández FJ; Ameneiros Lago E; Sesma Sánchez P
    An Med Interna; 2001 Mar; 18(3):171. PubMed ID: 11594194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Simvastatin-induced hepatitis].
    Roblin X; Becot F; Piquemal A; Baziz A
    Gastroenterol Clin Biol; 1992; 16(1):101. PubMed ID: 1537472
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview: long-term tolerability of lovastatin and simvastatin.
    Bilheimer DW
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):138-9. PubMed ID: 1315197
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.
    Stein CA; Goel S; Ghavamian R
    Invest New Drugs; 2007 Jun; 25(3):277-8. PubMed ID: 17216557
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of hepatitis caused by simvastatin].
    Feydy P; Bogomoletz WV
    Gastroenterol Clin Biol; 1991; 15(1):94-5. PubMed ID: 2010080
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhabdomyolysis, acute renal failure and hepatopathy induced by lovastatin monotherapy.
    Chu PH; Chen WJ; Chiang CW; Lee YS
    Jpn Heart J; 1997 Jul; 38(4):541-5. PubMed ID: 9350151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122].
    Müller T
    Nervenarzt; 2003 Aug; 74(8):726-7. PubMed ID: 12904874
    [No Abstract]   [Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor-induced impotence.
    Halkin A; Lossos IS; Mevorach D
    Ann Pharmacother; 1996 Feb; 30(2):192. PubMed ID: 8835058
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors.
    Ballarè M; Campanini M; Airoldi G; Zaccala G; Bertoncelli MC; Cornaglia G; Porzio M; Monteverde A
    Minerva Gastroenterol Dietol; 1992; 38(1):41-4. PubMed ID: 1520752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoglobinuric renal failure due to long-standing lovastatin therapy in a patient with pre-existing chronic renal insufficiency.
    Biesenbach G; Janko O; Stuby U; Zazgornik J
    Nephrol Dial Transplant; 1996 Oct; 11(10):2059-60. PubMed ID: 8918723
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin.
    Grimbert S; Pessayre D; Degott C; Benhamou JP
    Dig Dis Sci; 1994 Sep; 39(9):2032-3. PubMed ID: 8082513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin lesions due to treatment with simvastatin (Zocor).
    Feldmann R; Mainetti C; Saurat JH
    Dermatology; 1993; 186(4):272. PubMed ID: 8513195
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].
    Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A
    Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.